BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 10478243)

  • 1. Phases IB and II multidose trial of gadolinium texaphyrin, a radiation sensitizer detectable at MR imaging: preliminary results in brain metastases.
    Viala J; Vanel D; Meingan P; Lartigau E; Carde P; Renschler M
    Radiology; 1999 Sep; 212(3):755-9. PubMed ID: 10478243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I single-dose trial of gadolinium texaphyrin (Gd-Tex), a tumor selective radiation sensitizer detectable by magnetic resonance imaging.
    Rosenthal DI; Nurenberg P; Becerra CR; Frenkel EP; Carbone DP; Lum BL; Miller R; Engel J; Young S; Miles D; Renschler MF
    Clin Cancer Res; 1999 Apr; 5(4):739-45. PubMed ID: 10213207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter phase Ib/II trial of the radiation enhancer motexafin gadolinium in patients with brain metastases.
    Carde P; Timmerman R; Mehta MP; Koprowski CD; Ford J; Tishler RB; Miles D; Miller RA; Renschler MF
    J Clin Oncol; 2001 Apr; 19(7):2074-83. PubMed ID: 11283141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme.
    Ford JM; Seiferheld W; Alger JR; Wu G; Endicott TJ; Mehta M; Curran W; Phan SC
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):831-8. PubMed ID: 17560737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible renal toxicity resulting from high single doses of the new radiosensitizer gadolinium texaphyrin.
    Rosenthal DI; Becerra CR; Toto RD; Carbone DP; Frenkel EP
    Am J Clin Oncol; 2000 Dec; 23(6):593-8. PubMed ID: 11202804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis of cerebral metastasis with standard dose gadobutrol vs. a high dose protocol. Intraindividual evaluation of a phase II high dose study].
    Vogl TJ; Friebe CE; Balzer T; Mack MG; Steiner S; Schedel H; Pegios W; Lanksch W; Banzer D; Felix R
    Radiologe; 1995 Aug; 35(8):508-16. PubMed ID: 7568795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Motexafin gadolinium (MGd) as a contrast agent for intraoperative MRI.
    Hirschberg H; Wu GN; Madsen SJ
    Minim Invasive Neurosurg; 2007 Dec; 50(6):318-23. PubMed ID: 18210352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of immediate and delayed gadolinium-enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions.
    Uysal E; Erturk SM; Yildirim H; Seleker F; Basak M
    AJR Am J Roentgenol; 2007 Mar; 188(3):697-702. PubMed ID: 17312056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motexafin gadolinium: gadolinium (III) texaphyrin, gadolinium texaphyrin, Gd-Tex, GdT2B2, PCI 0120.
    Drugs R D; 2004; 5(1):52-7. PubMed ID: 14725495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsed reduced dose-rate radiotherapy as re-irradiation for brain metastasis in a patient with lung squamous-celled carcinoma.
    Li GH; Liu Y; Tang JL; Zhang D; Zhou P; Yang DQ; Ma CK
    Jpn J Clin Oncol; 2012 Sep; 42(9):856-60. PubMed ID: 22701036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging of reperfused myocardial infarction: comparison of necrosis-specific and intravascular contrast agents in a cat model.
    Lee SS; Goo HW; Park SB; Lim CH; Gong G; Seo JB; Lim TH
    Radiology; 2003 Mar; 226(3):739-47. PubMed ID: 12601203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP; Bachert P; Hamprecht F; Weber MA; Debus J; Schulz-Ertner D; Schlemmer HP; Kauczor HU
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of contrast enhancement in the pediatric spine at MR imaging with single- and triple-dose gadolinium.
    Tam JK; Bradley WG; Goergen SK; Chen DY; Pema PJ; Dubin MD; Teresi LM; Jordan JE
    Radiology; 1996 Jan; 198(1):273-8. PubMed ID: 8539393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database.
    Shaw E; Scott C; Suh J; Kadish S; Stea B; Hackman J; Pearlman A; Murray K; Gaspar L; Mehta M; Curran W; Gerber M
    J Clin Oncol; 2003 Jun; 21(12):2364-71. PubMed ID: 12805339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II clinical trial of gadoteridol injection, a low-osmolal magnetic resonance imaging contrast agent.
    Carvlin MJ; De Simone DN; Meeks MJ
    Invest Radiol; 1992 Aug; 27 Suppl 1():S16-21. PubMed ID: 1506148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gd-Tex Pharmacyclics Inc.
    Radford IR
    Curr Opin Investig Drugs; 2000 Dec; 1(4):524-8. PubMed ID: 11249709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization of blood-brain barrier disruption on MR images of cats with acute cerebral infarction: value of administering a high dose of contrast material.
    Runge VM; Kirsch JE; Wells JW; Dunworth JN; Woolfolk CE
    AJR Am J Roentgenol; 1994 Feb; 162(2):431-5. PubMed ID: 8310940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model.
    Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G
    Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
    Katakami N; Inaba Y; Sugata S; Tsurusaki M; Itoh T; Machida T; Tanaka H; Nakayama T; Morikawa T; Breuer J; Aitoku Y
    Invest Radiol; 2011 Jul; 46(7):411-8. PubMed ID: 21467949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-body MR imaging: evaluation of patients for metastases.
    Lauenstein TC; Goehde SC; Herborn CU; Goyen M; Oberhoff C; Debatin JF; Ruehm SG; Barkhausen J
    Radiology; 2004 Oct; 233(1):139-48. PubMed ID: 15317952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.